$ORCL

Tech giants are redirecting record cash to AI infrastructure, with 2026 spending projected at $667 billion—surpassing Dot-Com era investment intensity and cutting shareholder buybacks significantly.

Oracle pursues aggressive cloud expansion targeting $144B revenue by 2030, but faces stock decline, rising debt, and concentration risk from OpenAI dependency.

Pharmacovigilance market projected to grow threefold from $8.91B (2025) to $24.69B (2035), driven by stricter regulations and rising adverse drug reactions globally.

S&P 500 rose Tuesday as volatility fell, but diverging volatility signals and widening credit spreads warn of potential market pullback ahead of Nvidia earnings.

Masonite shareholders can join a class action lawsuit until April 2026, alleging the company hid acquisition proposals while conducting stock buybacks, harming investors.

Pentagon opens $151B SHIELD missile defense program to 2,400+ vendors. Companies compete for task orders in comprehensive ballistic and hypersonic defense initiative.

Four major companies face securities fraud lawsuits for misleading investors on AI spending, financial disclosures, and manufacturing claims. Investor filing deadlines approaching.

Procure-to-pay market projected to nearly double from $8.21B to $15.15B by 2033, driven by AI and cloud-based automation adoption across enterprises.

Oracle faces a class action lawsuit alleging it failed to disclose financial risks tied to its AI infrastructure investments, citing misaligned capital spending and revenue growth.

Healthcare workforce management systems market expected to triple to $6.26B by 2035, driven by hospitals adopting digital solutions to address staffing challenges and labor pressures.

Two energy infrastructure companies offer attractive 6-7% dividend yields, benefiting from data center demand surge and stable fee-based revenue models.

Ardent Health investors must join securities class action by March 9, 2026, alleging company misrepresented financial reporting and insurance coverage practices.

Oracle faces a securities class action lawsuit over allegedly misleading AI strategy disclosures. Investors must act by April 6, 2026, regarding stock purchased between June-December 2025.

Growth ETFs offer buying opportunities as tech faces 2026 headwinds. VUG and MGK provide diversified exposure, while IGV's tech decline may attract contrarian investors.

Oracle's cloud division grows 66% yearly with $523B AI backlog, but aggressive expansion increases debt and customer concentration risk with OpenAI.

Oracle stock dropped 5% after Nvidia cut its OpenAI investment commitment from $100B to $30B, raising concerns about OpenAI's funding and Oracle's $300B infrastructure deal viability.

Cardiology EHR market projected to grow from $3.52B in 2026 to $5.44B by 2035, driven by digitization and regulatory requirements.

Class action lawsuits filed against Paysafe and Oracle for material omissions in financial disclosures. Paysafe failed to disclose high-risk clients; Oracle misrepresented AI infrastructure costs.

Oracle faces a securities class action lawsuit alleging it misrepresented AI infrastructure strategy disclosures, failing to reveal substantial capital expenditures and associated risks to investors between June-December 2025.

AMD strengthens AI chip market position through partnerships with OpenAI, Oracle, and TCS. Analysts project continued enterprise adoption and revenue growth in 2026.